Generalised myasthenia gravis - treatment refractory initial authority application form (PB396)

Use this form to apply for initial PBS-subsidised treatment with ravulizumab, rozanolixizumab or zilucoplan for treatment refractory generalised myasthenia gravis.

Page last updated: 1 July 2026.
QC 83707